Transitional care in pediatric inflammatory bowel disease: current strategies and future directions - a narrative

Pawel Rucinski1, Katarzyna Akutko1, Tomasz Pytrus1

  • 12nd Department and Clinic of Paediatrics, Gastroenterology and Nutrition, Medical University of Wroclaw, Poland.

Insights

Structured transition programs significantly improve outcomes for pediatric inflammatory bowel disease (IBD) patients moving to adult care. Despite proven benefits, formal protocols are often lacking, highlighting a need for standardized approaches.

Area of Science:

  • Pediatric Gastroenterology
  • Adult Gastroenterology
  • Healthcare Transition

Background:

  • Approximately 25% of inflammatory bowel disease (IBD) cases begin in childhood.
  • Pediatric-onset IBD presents differently than adult-onset disease.
  • Transitioning from pediatric to adult healthcare is a critical juncture for young IBD patients.

Purpose of the Study:

  • To review the literature on structured transition programs for pediatric IBD patients.
  • To identify barriers and facilitators to successful healthcare transition.
  • To highlight the importance of standardized, patient-centered transition protocols.

Main Methods:

  • Literature review of PubMed, Scopus, and Web of Science databases.
  • Analysis of articles published within the last 6 years.
  • Synthesis of findings regarding transition program effectiveness and challenges.

Main Results:

  • Structured transition programs are associated with improved adherence, reduced relapse rates, and fewer hospitalizations.
  • Many healthcare centers lack formal transition protocols.
  • Barriers include insufficient provider training, poor inter-team communication, and resource limitations.
  • Digital health tools and tailored education show promise in overcoming gaps.

Conclusions:

  • Standardized, evidence-based transition protocols are essential for young adults with IBD.
  • A multidisciplinary, patient-centered approach is crucial for managing complex medical and psychosocial needs.
  • Future research should explore digital interventions, long-term outcomes, and cost-effectiveness.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...